Clinical trial participants reported significant pain relief from obesity-related knee arthritis after taking semaglutide, allowing them to engage more in physical activities such as walking.
'They got a therapy that was so effective that they more or less were treated out of the study,' says Henning Bliddal, highlighting the efficacy of the drug.
The findings could be valuable for individuals suffering from knee osteoarthritis, as noted by Leigh Callahan, emphasizing the wider impact of the research.
Osteoarthritis often leads to joint stiffness and pain, significantly affecting the quality of life in aging populations, especially those with obesity.
Collection
[
|
...
]